Protagonist Therapeutics, Inc. (PTGX) Cash Flow Annual - Discounting Cash Flows
PTGX
Protagonist Therapeutics, Inc.
PTGX (NASDAQ)
Period Ending: LTM
(Last Twelve Months)
2024
12-31
2023
12-31
2022
12-31
2021
12-31
2020
12-31
2019
12-31
2018
12-31
2017
12-31
2016
12-31
2015
12-31
2014
12-31
Report Filing: 2025-11-06 2025-02-21 2024-02-27 2023-03-15 2022-02-28 2021-03-10 2020-03-10 2019-03-12 2018-03-07 2017-03-07 2015-12-31 2014-12-31
Net Income/Starting Line 45.91 275.2 -78.95 -127.4 -125.6 -66.15 -77.19 -38.92 -36.96 -37.18 -14.86 -11.07
Cash From Operating Activities 65.47 184.2 -70.24 -108.1 -107.9 -72.48 -41.53 -49.95 3.87 -29.97 -14.38 -7.74
Depreciation and Amortization 1.44 2.9 3.31 3.37 2.77 2.56 2.5 0.527 0.406 0.317 0.247 0.258
Deferred Income Tax 0 0 0 0 0 1.44 -0.775 -0.658 0 0.151 -0.008 0
Stock Based Compensation 33.81 37.55 29.29 24.2 16.39 7.9 8.35 6.92 4.24 2.13 0.099 0.042
Other Non-Cash Items 3.16 -8.88 -4.38 -0.549 1.83 0.781 -0.557 0.206 0.625 4.72 0.083 1.77
Changes in Working Capital -18.85 -122.6 -19.51 -7.77 -3.31 -19.02 26.14 -18.02 35.56 -0.112 0.052 1.26
Accounts Receivable -0.045 -155 0 4.24 -0.915 3.34 -0.757 -2.77 -1.82 -1.59 -0.192 0
Inventory 0 0 0 -4.24 0.915 -3.34 0.757 3.85 5.53 0 0 0
Accounts Payable 2.6 0.842 -2.93 2.04 -1.39 0.309 -3 4.43 0.091 -0.115 0.898 0.179
Deferred Revenue -21.4 31.55 -16.58 -9.81 -1.92 -19.32 29.14 -23.53 31.75 0.003 -0.846 1.08
Other Working Capital 0 0 0 0 0 0 0 0 0 1.59 0.192 0
Cash From Investing Activities -106.9 -299.5 -39.26 91.47 -15.86 -90.97 -53.71 2.21 15.82 -59.33 -8.26 -0.299
Investments in Property Plant and Equipment -1.76 -1.35 -0.609 -0.795 -1.1 -0.471 -0.967 -0.486 -0.666 -0.379 -0.399 -0.299
Payments for Acquisitions 0 0 0 -91.47 14.76 90.49 52.74 0 0 0.032 0 0
Purchases of Securities -556.7 -621.7 -191 -214.9 -286.6 -280 -166.9 -71.06 -39.55 -73.17 -7.87 0
Sales and Maturities of Investments 451.6 323.6 152.4 307.1 271.8 189.5 114.2 73.76 56.03 14.19 0 0
Other Investing Activities -0.005 0 0 91.47 -14.76 -90.49 -52.74 2.7 16.49 0.032 -7.87 0
Cash From Financing Activities 24.06 25.85 170.5 18.84 129.9 247.6 46.04 24.11 65.55 106.3 17.42 9
Debt Repayment 0 0 0 0 0 -10.52 9.77 0 0 0 0 0
Common Stock Issued 20.51 26.45 132.1 14.55 123.8 255.4 34.49 23.18 64.55 83.65 17.42 0
Common Stock Repurchased 0 0 0 0 0 0 0 0 0 0 0 0
Dividends Paid 0 0 0 0 0 0 0 0 0 0 0 0
Other Financing Activities 3.55 -0.6 38.38 4.29 6.09 2.79 1.78 0.934 1.01 22.66 17.42 9
Effect of Forex Changes on Cash 0.003 0 0 -0.09 -0.126 0.175 -0.026 -0.177 0.146 0.022 -0.039 -0.097
Net Change in Cash 16.24 -89.48 60.98 2.08 6.07 84.35 -49.23 -23.8 85.39 17.03 -5.27 0.864
Cash at Beginning of Period 97.47 187 126 123.9 117.8 33.47 82.69 106.5 21.09 4.05 9.32 8.46
Cash at End of Period 113.7 97.47 187 126 123.9 117.8 33.47 82.69 106.5 21.08 4.05 9.32
Free Cash Flow 63.71 182.8 -70.84 -108.9 -109 -72.95 -42.49 -50.43 3.21 -30.35 -14.78 -8.04
Operating Cash Flow 65.47 184.2 -70.24 -108.1 -107.9 -72.48 -41.53 -49.95 3.87 -29.97 -14.38 -7.74
Capital Expenditure -1.76 -1.35 -0.609 -0.795 -1.1 -0.471 -0.967 -0.486 -0.666 -0.379 -0.399 -0.299
discounting cash flows home logo

Discounting Cash Flows

Are you finding our services helpful? Review us on trustpilot logo Trustpilot
Have a question? Contact us
Want to become our sponsor?
Check out our Affiliate Program